Our Team

Led by Dr. Bekim Sadikovic, the Scientific and Clinical Director of the Clinical Genome Centre in London, Canada, the team at EpiSign™ Inc. has developed EpiSign METRIC, the first-ever clinically validated epigenetic testing software that can provide more accurate diagnoses for genetic conditions, including rare diseases, particularly in cases where traditional testing methods fail to provide a conclusive result.

The team at EpiSign™ Inc. is actively pursuing commercial partnerships for early adopters of the METRIC platform to bring cutting-edge epigenomics to the market and provide access to next-generation diagnostics to those you need it.

The team also collaborates with institutions across Canada to measure the clinical impact of EpiSign™ across the country through the EpiSign™-CA Clinical Trial and implements the technology internationally in collaboration with institutions across 15 countries.

Additionally, the team's ongoing research continues to uncover DNA methylation patterns, or episignatures, for new conditions and disorders that expand the ever-growing EpiSign™ Knowledge Database.